v3.24.1.u1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Research and development expenses $ 2,061 $ 1,885
Marketing expenses 822 759
General and administrative expenses 2,028 2,118
Total operating loss 4,911 4,762
Financial income, net (2) (28)
Loss for the year $ 4,909 $ 4,734
Loss per share    
Basic loss per common stock $ (0.07) $ (0.07)
Dilutive loss per common stock $ (0.07) $ (0.07)

Source